Hikma Specialty USA Inc. c/o Velocity BioGroup
Registered Principal Details
Business Or Interest:
Pharmaceuticals
Lobbying Interests:
Ensure Kloxxado, 8mg Naloxone is available in the state.
CEO Name:
Pat Trifunov
Pharmaceuticals
Lobbying Interests:
Ensure Kloxxado, 8mg Naloxone is available in the state.
CEO Name:
Pat Trifunov
Contact
PT
Pat Trifunov
400 North Park Avenue, Suite 10-2, Box 566
Breckenridge, CO 80424
(610) 357-2402
patt@velocitybiogroup.com
400 North Park Avenue, Suite 10-2, Box 566
Breckenridge, CO 80424
(610) 357-2402
patt@velocitybiogroup.com
Authorized Lobbyists
| Lobbyist Name | Exclusive Duties | Authorized On | Withdrawn On |
|---|---|---|---|
| Heidi McCracken | Exclusive Duties Yes | Authorized On 7/1/2021 | Withdrawn On N/A |
Lobbying Interests
No lobbying interests found.
Total Lobbying Effort
| 2021 July - December |
2022 January - June |
2022 July - December |
Total | |
|---|---|---|---|---|
| Total Lobbying Expenditures | 2021 July - December $0.00 |
2022 January - June $0.00 |
2022 July - December $0.00 |
Total $0.00 |
| Total Hours Communicating | 2021 July - December 0.00 |
2022 January - June 0.00 |
2022 July - December 0.00 |
Total 0.00 |
| Total Hours Other | 2021 July - December 0.00 |
2022 January - June 0.00 |
2022 July - December 0.00 |
Total 0.00 |
Percent Allocation of Lobbying Effort
Legislative Bills/Resolutions
No legislative bills/resolutions found.
Budget Bill Subjects
No budget bill subjects found.
Administrative Rulemaking Proceedings
No administrative rulemaking proceedings found.
Topics Not Yet Assigned A Bill Or Rule Number
No topics found.
Minor Efforts
No minor efforts found.
Other Matters
Includes time spent on:
- Gubernatorial nominations
- Matters on which the organization made no lobbying communication